BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9514899)

  • 1. Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats.
    Wang C; Chao C; Madeddu P; Chao L; Chao J
    Biochem Biophys Res Commun; 1998 Mar; 244(2):449-54. PubMed ID: 9514899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein gene therapy in newborn and adult hypertensive rats.
    Chao J; Yang Z; Jin L; Lin KF; Chao L
    Can J Physiol Pharmacol; 1997 Jun; 75(6):750-6. PubMed ID: 9276159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
    Jin L; Zhang JJ; Chao L; Chao J
    Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein gene therapy: a new strategy for hypertensive diseases.
    Chao J; Chao L
    Immunopharmacology; 1997 Jun; 36(2-3):229-36. PubMed ID: 9228551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
    Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
    Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats.
    Wang T; Hou LB; Liu ZJ; Wang Y; Chen CL; Xiao X; Wang DW
    Acta Pharmacol Sin; 2007 Dec; 28(12):1898-906. PubMed ID: 18031602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
    Chao J; Jin L; Chen LM; Chen VC; Chao L
    Hum Gene Ther; 1996 May; 7(8):901-11. PubMed ID: 8727504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.
    Wang C; Chao L; Chao J
    J Clin Invest; 1995 Apr; 95(4):1710-6. PubMed ID: 7535795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats.
    Chen LM; Chao L; Chao J
    Hum Gene Ther; 1997 Feb; 8(3):341-7. PubMed ID: 9048201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer and expression in rat anastomotic artery in vivo using adenoviral vector.
    Huang Z; Guo J; Guo S
    Chin Med J (Engl); 2001 Jun; 114(6):650-3. PubMed ID: 11780446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
    Murakami H; Yayama K; Chao L; Chao J
    Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
    Chao J; Zhang JJ; Lin KF; Chao L
    Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
    Chao J; Chao L
    Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats.
    Zhang JJ; Wang C; Lin KF; Chao L; Chao J
    Clin Exp Hypertens; 1999 Oct; 21(7):1145-60. PubMed ID: 10513833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of direct gene transfer into rat carotid arteries mediated by adenoviral vector].
    Huang Z; Guo J; Guo S
    Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):680-1. PubMed ID: 11829926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-associated virus-mediated human kallikrein gene therapy prevents high-salt diet-induced hypertension without effect on basal blood pressure.
    Yan JT; Wang T; Li J; Xiao X; Wang DW
    Acta Pharmacol Sin; 2008 Jul; 29(7):808-14. PubMed ID: 18565278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats.
    Kumai Y; Ooboshi H; Kitazono T; Takada J; Ibayashi S; Fujishima M; Iida M
    Exp Neurol; 2003 Dec; 184(2):904-11. PubMed ID: 14769382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain.
    Chu Y; Iida S; Lund DD; Weiss RM; DiBona GF; Watanabe Y; Faraci FM; Heistad DD
    Circ Res; 2003 Mar; 92(4):461-8. PubMed ID: 12600899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    Yayama K; Wang C; Chao L; Chao J
    Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.